Executive Summary
Across 50 SEC filings for March 20, 2026, dominant themes include advancing SPAC mergers (CoinShares, Einride, Pelican/Greenland) with high redemptions signaling investor caution, accretive M&A in healthcare (Embecta, Prestige, PSA/NSA), and robust revenue growth in tech/aerospace (Aeva +99% YoY, Firefly +163% YoY) offset by widening losses and yield compression in BDCs/investment firms (avg yield drop to 9.1% from 10.0%). Retail (Dollar General +5.2% YoY sales, +107 bps gross margin) and biotech (Cellectis +61.7% revenue) show resilience, but REITs like Belpointe report surging losses (+68% YoY) amid debt growth (+47%). Aggregate trends: 12/20 financial reporters grew revenue >50% YoY (avg +80%), but 8/12 saw net losses widen (avg +40%), with mixed sentiments in 70% of high-materiality filings. M&A valuations appear reasonable (Prestige 11x EBITDA, Embecta £150M for £69M rev), while SPAC redemptions averaged 60%+. Implications: Opportunities in post-merger listings and accretive deals, risks in dilutive financings and operational cash burns.
Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from March 19, 2026.
Investment Signals(12)
- CoinShares(BULLISH)▲
Scheme approved by majorities, US/France/Jersey approvals secured, Nasdaq listing imminent March 31
- Aeva Technologies↓(BULLISH)▲
FY2025 revenue +99% YoY to $18.1M, gross loss narrowed 83% to $0.7M, cash + to $72.3M via $128.6M financing
- Papa Medical↓(BULLISH)▲
S-1/A for $15M IPO at $4/share, Nasdaq 'PAPA' listing, emerging growth in hemp E-vapors
- QIAGEN↓(BULLISH)▲
FY2025 sales +6% YoY to $2.09B, consumables +7%, gross margin +1330 bps to 62.2%
- Embecta Corp↓(BULLISH)▲
Acquiring Owen Mumford for £150M (upfront £100M), adds £69.4M rev, accretive to adj. NII post-FY2028, high-single-digit ROIC by yr4
- Prestige Consumer↓(BULLISH)▲
$1.045B Breathe Right acquisition (~$200M rev, $95M EBITDA at 11x), immediately accretive to rev/margins/EPS/FCF, pro-forma rev ~$1.3B
- Firefly Aerospace↓(BULLISH)▲
2025 revenue +163% YoY to $159.9M (Spacecraft +244%), gross profit swing to +$30.7M, cash $793M
- Dollar General↓(BULLISH)▲
FY2025 sales +5.2% YoY to $42.7B, op profit +28.6% to $2.2B, gross margin +107 bps to 30.66%, EPS +34.1% to $6.85
- Yellowstone Midco↓(BULLISH)▲
2025 revenue +52% YoY to $386M, gross profit x3 to $75M (margin +700 bps to 20%), Adj EBITDA -43M to -8M
- News Corp↓(BULLISH)▲
Ongoing $1B buyback program for NWSA/NWS, daily ASX reporting signals active capital return
- Primoris Services↓(BULLISH)▲
2025 record milestones, strong cash flow, balance sheet strength ahead of April 30 AGM
- Bio-Path Holdings↓(BULLISH)▲
Wyoming domestication complete, new Scientific Advisory Board with oncology experts, 100k options issued
Risk Flags(9)
- National Storage Affiliates (M&A Severance)[HIGH RISK]▼
Performance LTIP Units cancelled without payment, severance up to 52 weeks but requires termination/release, mixed employee treatment in PSA deal
- Aeva Technologies (Balance Sheet)[HIGH RISK]▼
Stockholders' equity -87% to $13.2M from $99.4M on $96.7M convertible notes, net loss -4% to $145.4M
- Belpointe PREP (Losses/Debt)[HIGH RISK]▼
Net loss +68% YoY to $40M, loss per unit to $(10.72), debt +47% to $260.6M, negative NOI in segments
- Cellectis (Losses/Cash)[HIGH RISK]▼
Net loss +83.9% to $67.6M, cash -19.8% to $208.7M, equity -42.1% to $75.9M despite rev +61.7%
- Pelican Acquisition (Redemptions)[HIGH RISK]▼
63% shares redeemed (7.56M for $77.7M at $10.28), major trust outflow pre-Greenland merger close March 24
- Firefly Aerospace (Cash Burn)[MEDIUM RISK]▼
Op cash used +30% to $204.9M, net loss +29% to $298.3M, Adj EBITDA -$198.6M
- BDC Portfolio Firms (Yield Compression)[MEDIUM RISK]▼
4/4 BDCs yields down to ~9.1% from 10.0% YoY, unrealized dep'n shifts (e.g., $6.7M vs +$2.1M)
- Cingulate (Dilution)[MEDIUM RISK]▼
S-3 for 3.5M shares resale under $25M Lincoln Park deal, commitment shares issued, min price $0.50 limits but dilution risk
- Einride AB (SPAC)[MEDIUM RISK]▼
Investor presentation heavy on disclaimers/risks, no financials, Legato merger pending
Opportunities(8)
- CoinShares/Nasdaq Listing(OPPORTUNITY)◆
Court sanction March 30, effective March 31, last Stockholm trading March 20 – buy pre-relisting upside
- Einride AB (Autonomous Logistics)(OPPORTUNITY)◆
$92M ARR (+50% past 6mo), $800M potential, Gen3 trucks 2027, SPAC combo with Legato
- Pelican/Greenland Energy↓(OPPORTUNITY)◆
Merger approved, close ~March 24, Nasdaq 'GLND' March 25 despite redemptions – post-SPAC momentum
- Embecta/Owen Mumford↓(OPPORTUNITY)◆
Drug delivery expansion, 80% UK/US rev, dilutive FY27 but accretive after, close Q3 2026
- Prestige/Breathe Right↓(OPPORTUNITY)◆
#1 nasal strip, 71% US/Canada, path to <3x leverage by FY28, H1 FY27 close
- Aeva Technologies (LiDAR)(OPPORTUNITY)◆
Revenue doubling, NA 74% rev, $72M cash for growth despite notes
- Firefly Aerospace↓(OPPORTUNITY)◆
Launch/Spacecraft hypergrowth, $793M cash post-$1.3B financing, scale potential
- Dollar General (Retail)(OPPORTUNITY)◆
Category growth (home +6.7%, seasonal +6.2%), margin expansion, sales/sqft + to $270
Sector Themes(5)
- SPAC Mergers Advancing◆
5/50 filings (CoinShares, Einride, Pelican/Greenland, ACP IPO) show approvals/redemptions avg 60%+, closes March 24-31 – watch post-listing volatility but logistics/energy targets bullish [IMPLICATION: Tactical entry post-redemption]
- Healthcare M&A Accretive◆
Embecta/Prestige/NSA deals add rev (avg +20-30%), reasonable multiples (9-11x), immediate EPS/FCF boost despite short-term dilution [IMPLICATION: Portfolio add for growth/defense]
- Revenue Acceleration in Tech/Aerospace◆
6/12 (Aeva +99%, Firefly +163%, AITX orders) >50% YoY growth, but losses widen avg +30% on R&D – cash raises support [IMPLICATION: High-beta growth bets]
- BDC/Investment Yield Pressure◆
5 firms yields -0.9-1.0% to 8.8-9.1%, portfolios +72-110% assets but NAV slips 0.4-1.2%, first-lien focus 99% [IMPLICATION: Income caution, rate sensitivity avg +/-18% NII on 250bps move]
- ABS Servicing Routine◆
15/50 10-K appendices confirm compliance (no deficiencies), N/A on reporting/remittances – stable but low alpha [IMPLICATION: Background noise, no action]
Watch List(7)
- CoinShares👁
Court sanction March 30, effectiveness March 31 – monitor Nasdaq listing debut [March 31, 2026]
Merger close ~March 24, 'GLND' trading March 25 – post-SPAC performance after 63% redemptions [March 24-25, 2026]
Special meeting reconvene April 21 for 2x share authorization increase – vote outcome [April 21, 2026]
Virtual AGM April 30, elect directors/approve comp/auditors – 2025 results commentary [April 30, 2026]
Q1 2026 earnings April 22 – $4.4B AUM trends [April 22, 2026]
- Embecta Acquisition👁
Regulatory approvals for Owen Mumford close Q3 FY2026 – financing/ROIC updates [Q3 2026]
- Prestige Acquisition👁
H1 FY27 close for Breathe Right, pro-forma leverage path to <3x FY28 [H1 FY27]
Filing Analyses(50)
20-03-2026
CoinShares announced on March 19, 2026, that the requisite majorities of Scheme Shareholders and CoinShares Shareholders approved the Scheme of Arrangement at the Jersey Court Meeting and Scheme General Meeting, respectively, supporting the merger transaction with Vine Hill Capital Investment Corp and Odysseus Holdings Limited to facilitate a US Nasdaq listing. Key antitrust and regulatory approvals in the US, France, and Jersey (Conditions 6, 7, and 8) have been satisfied, with no reported issues or declines in approval thresholds. The transaction awaits court sanction on March 30, 2026, and expected effectiveness on March 31, 2026.
- ·Vine Hill is a SPAC sponsored by an affiliate of Vine Hill Capital Partners.
- ·Last day of dealings and registration of transfers of CoinShares Shares on Nasdaq Stockholm: March 20, 2026.
- ·Scheme Circular published on February 18, 2026.
- ·Transaction initially announced on September 8, 2025.
20-03-2026
This employee FAQ details the treatment of equity awards, FY 2026 bonuses, and severance under the National Storage Affiliates Trust Severance Plan amid Public Storage’s proposed acquisition of NSA. Unvested restricted shares and most Partnership LTIP Units vest fully prior to closing without requiring continued employment, while performance-based LTIP Units granted in 2026 are cancelled without payment. Eligible employees may receive prorated FY 2026 target bonuses and severance ranging from 4-52 weeks of pay based on tier and service, plus housing payments up to $3,000, but severance is not automatic and requires qualifying termination.
- ·Severance multiples for corporate employees: Tier 1 (SVPs) 20-52 weeks; Tier 2 (VPs) 16-36 weeks; Tier 3 (Directors) 12-24 weeks; Tier 4 (Managers) 8-16 weeks; Tier 5 (others) 4-12 weeks of weekly base pay plus bonus.
- ·Field employee severance: 4-12 weeks of base pay based on years of service tiers.
- ·FY 2026 bonus proration: days from January 1, 2026 to merger date divided by 365, paid after 90 days post-closing employment or upon qualifying termination with release.
- ·Housing eligibility: loss of NSA-provided housing within one year after March 16, 2026, while remaining employed.
- ·Reference to NSA OP Unitholder FAQ filed March 18, 2026 for OP Unit details.
20-03-2026
Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 20, 2026, announcing a press release stating that its RAD division has booked an order for 5 RIO 360 units destined for the Downtown Civic Center in a major Midwest city. This development underscores demand for AITX's AI-driven security solutions amid otherwise limited financial details in the filing.
- ·Filing includes Exhibit 99.1: Press release dated March 20, 2026
20-03-2026
Aeva Technologies reported revenue of $18.1M for FY 2025, nearly doubling 99% YoY from $9.1M, with North America contributing 74% of revenue, while gross loss narrowed 83% to $0.7M. However, net loss improved only 4% to $145.4M from $152.3M amid a $21.5M negative change in warrant liability and high R&D expenses of $85.4M (down 17% YoY), leading to stockholders' equity dropping sharply to $13.2M from $99.4M due to $96.7M in new convertible notes. Cash and equivalents rose to $72.3M, supported by $128.6M in financing inflows.
- ·Revenue by geography FY2025: North America $13.3M (74%), Europe $3.9M (21%), Asia $0.6M (3%).
- ·Cash from financing FY2025: $128.6M primarily from $100M convertible notes and $32.5M private placement.
- ·Marketable securities declined to $49.6M from $83.1M as of Dec 31 2025.
- ·Weighted-average shares basic/diluted: 57.0M in FY2025 vs 53.4M in FY2024; net loss per share $(2.55) vs $(2.85).
20-03-2026
Einride AB held a Capital Markets Day on March 19, 2026, outlining its platform technology for transitioning logistics to electric and autonomous operations via the Saga AI platform, with $92M ARR in signed contracts ($40-50M deployed) and over $800M in potential ARR from joint business plans. The company reported strong recent momentum, including over 50% ARR growth in contracts over the past six months, addition of four autonomous customers, and nearly doubled driverless hours. Operations span seven countries with 30 customers, addressing a $4T transport market plagued by 11% US asset utilization.
- ·Founded in 2016, first customer live in 2020
- ·Generation 2 autonomous trucks live since 2023; Generation 3 expected early 2027
- ·Addresses three key industry cost buckets: asset (via higher utilization), labor (via autonomy), energy (via long-term contracts and optimization)
20-03-2026
Einride AB filed a Rule 425 under the Securities Act, making available an investor presentation on March 19, 2026, regarding the proposed business combination with Legato Merger Corp. III (Commission File No. 001-41945). The document consists primarily of extensive legal disclaimers, forward-looking statement cautions, and risk factors related to the transaction, with no financial metrics, performance data, or period comparisons disclosed.
- ·Filed pursuant to Rule 425 and deemed filed under Rule 14a-12
- ·Legato prospectus dated February 5, 2024, filed with SEC on February 6, 2024
20-03-2026
Papa Medical Inc., a provider of Hemp cannabinoid E-vapors and dosing solutions under the Cannapresso brand, filed Amendment No. 1 to its S-1 registration statement on March 19, 2026, for an IPO of 3,750,000 shares of Class A common stock at $4.00 per share, targeting $15M in gross proceeds before underwriting discounts. Net proceeds to the company are estimated at $13.95M, with an over-allotment option for 562,500 additional shares bringing totals to $17.25M gross and $16.04M net. The company, an emerging growth company and controlled entity (CEO Jian Hua holds 96.57% voting power post-offering), intends to list on Nasdaq under 'PAPA'.
- ·Company classified under SIC 2111 (Cigarettes), incorporated in Delaware with EIN 99-0986423.
- ·Principal offices at 202 North California Ave, City of Industry, CA 91744.
- ·Underwriters' over-allotment option exercisable for 45 days from prospectus date.
- ·Emerging growth company, smaller reporting company, and controlled company under Nasdaq rules.
20-03-2026
ACP Holdings Acquisition Corp., a blank check company focused on real estate & construction, filed an S-1/A registration statement (No. 333-294120) on March 20, 2026, for its initial public offering of units including Class A Ordinary Shares and warrants exercisable at $11.50. Union Street Sponsor, LLC acquired 7,666,667 Class B Ordinary Shares for $25,000 on January 29, 2026, with up to 1,000,000 subject to forfeiture to maintain 25% ownership post-IPO, and committed to purchase 390,000 Private Units. Proceeds from the IPO and Private Units will be deposited into a trust account with Odyssey Transfer & Trust Company.
- ·Company headquartered at 3131 Eastside, Houston, TX 77098.
- ·Standard Industrial Classification: Blank Checks [6770].
- ·Fiscal year end: December 31.
- ·EIN: 98-1923384.
20-03-2026
Bio-Path Holdings, Inc. completed its domestication to Wyoming on March 5, 2026, and amended its articles of incorporation to authorize a new Series S Preferred Stock class with 51 shares, each convertible into one common share and holding 1% of diluted voting power. Effective February 10, 2026, Wendy M. Charles, PhD, MS, CIP, CCRP and Michael Hickey were appointed to the newly created Scientific Advisory Board, each signing a three-year agreement and receiving 100,000 stock options with a $0.06 exercise price and three-year term. No financial results or performance metrics were reported.
- ·Options have a three-year expiration and are subject to adjustment.
- ·Dr. Charles specializes in clinical research, regulatory compliance, oncology, and health IT.
- ·Mr. Hickey is VP Clinical Operations at Processa Pharmaceuticals with prior experience at Amgen and Biomarin.
20-03-2026
BigBear.ai Holdings, Inc. announced the reconvening of its Special Meeting of Stockholders on April 21, 2026, at 2:00 p.m. ET (originally convened December 1, 2025, and adjourned to March 18, 2026) to vote on Proposal 1: amending the Second Amended and Restated Certificate of Incorporation to increase authorized common shares from 500 million to 1 billion. The record date is March 30, 2026, with voting deadline April 20, 2026, 11:59 p.m. ET; previously submitted proxies will be voted unless revoked, and stockholders are urged to vote 'FOR' Proposal 1.
- ·Virtual meeting URL: www.virtualshareholdermeeting.com/BBAI2026
- ·Proxy voting options: Internet (www.proxyvote.com), Telephone (1-800-690-6903), Mail
- ·Proxy solicitor contact: (800) 662-5200 or BBAI@info.morrowsodali.com
20-03-2026
QIAGEN N.V. reported FY2025 net sales of $2.09B, up 6% YoY from $1.98B in FY2024, driven by 7% growth in consumables (90% of sales) and 10% increase in EMEA revenues. However, instrumentation sales declined 2% to $213.6M and Asia Pacific, Japan & Rest of World revenues fell 2% to $290.7M. Gross profit rose 34% to $1.30B with margin expansion to 62.2% from 48.9%, while product groups like Sample Technologies (+3%) and Other (+41%) showed varied performance.
- ·FY2023 total net sales were $1,965.3M.
- ·Instrumentation sales declined from $239.1M in FY2023 to $218.0M in FY2024 (-9%) and $213.6M in FY2025 (-2%).
- ·Employee functions stable: Sales 38% (up from 37%), Production 27% (down from 28%), R&D 17% (down from 18%) in FY2025.
20-03-2026
Appendix B of the 10-K provides servicing criteria compliance disclosures under Regulation AB for asset-backed securities, detailing how criteria are handled by Unknown Company, PBLS1, CoreLogic, and Midland—mostly performed directly or by responsible vendors/subservicers. Several criteria are marked as inapplicable or not performed, such as maintaining back-up servicers (1122(d)(1)(iii)), certain investor reporting reconciliations (e.g., 1122(d)(3)(i)(B)-(D)), and external enhancements (1122(d)(4)(xv)). No quantitative performance metrics, deficiencies, or exceptions are reported.
- ·Filing date: March 20, 2026
- ·Standard timeframes referenced include deposits/postings within 2 business days, reconciliations within 30 calendar days, and resolution of reconciling items within 90 calendar days
20-03-2026
Janus Henderson filed a definitive proxy statement with the SEC on March 11, 2026, regarding a proposed transaction, which was first mailed to shareholders on or about March 12, 2026; the Funds filed their definitive proxy statements on March 2, 2026. A joint Schedule 13E-3 transaction statement was also filed on March 11, 2026. Investors and security holders are urged to review these documents and other SEC filings for complete details on the transaction and participants in the proxy solicitation.
- ·Janus Henderson Annual Meeting Proxy Statement filed March 21, 2025
- ·SEC website: https://www.sec.gov
- ·Janus Henderson investor relations: https://ir.janushenderson.com
20-03-2026
Janus Henderson issued a DEFA14A filing on March 20, 2026, providing additional information on proxy solicitations for a proposed transaction, including definitive proxy statements filed on March 11, 2026 (Janus Henderson) and March 2, 2026 (Funds), and a joint Schedule 13E-3 on March 11, 2026. The filing urges investors to review these documents and other SEC filings for details on the transaction, participants, and interests of directors/executive officers. No financial metrics or performance data are disclosed in this supplemental proxy communication.
- ·Janus Henderson Annual Meeting Proxy Statement filed March 21, 2025.
- ·Janus Henderson proxy first mailed to shareholders on or about March 12, 2026.
- ·SEC resources: https://www.sec.gov and https://ir.janushenderson.com.
20-03-2026
Consilio Wealth Advisors, LLC reported a portfolio of $341.9M across 98 positions as of December 31, 2025, with no indicated changes in holdings structure. Top holdings include iShares Core S&P 500 ETF at $71.5M (104,361 shares), Microsoft Corp at $29.4M (60,779 shares), and Amazon.com Inc at $26.4M (114,211 shares), reflecting a diversified mix of equities and ETFs. The report shows no derivatives positions (puts/calls at 0).
- ·Filing submitted March 20, 2026 for period ending December 31, 2025
- ·All positions held as sole voting authority with no shared/other discretionary shares
- ·No put or call options reported (all values 0)
20-03-2026
Janus Henderson filed a DEFA14A additional proxy statement on March 20, 2026, providing supplemental information on a proposed transaction, following its definitive proxy statement filed on March 11, 2026 (mailed March 12), and a joint Schedule 13E-3 on the same date; the Funds filed their definitive proxies on March 2, 2026. The filing discloses participants in the proxy solicitation, including directors, executives, and employees of Janus Henderson and the Funds, with ownership details referenced in prior SEC filings. Investors are urged to review full proxy statements, Schedule 13E-3, and other documents on the SEC website or Janus Henderson's IR site for complete information.
- ·Janus Henderson Annual Meeting Proxy Statement filed with SEC on March 21, 2025, contains director and executive ownership information.
- ·Funds' current statement of additional information details trustees and executive officers' ownership.
- ·Updates to participant holdings reflected in Forms 3 and 4 filed with SEC.
20-03-2026
Janus Henderson filed a DEFA14A additional proxy statement on March 20, 2026, providing supplemental disclosures for a proposed transaction, including references to definitive proxy statements filed on March 11, 2026 (mailed March 12) and Schedule 13E-3, as well as Funds' proxies filed March 2, 2026. The filing urges shareholders to review these documents for details on the transaction and identifies Janus Henderson directors, executives, and Fund managers as potential solicitation participants, with ownership details in prior SEC filings like the 2025 Annual Meeting Proxy Statement filed March 21, 2025. No financial metrics or performance data are disclosed in this procedural filing.
- ·Janus Henderson definitive proxy filed March 11, 2026; Funds proxies filed March 2, 2026; Schedule 13E-3 filed March 11, 2026
- ·Annual Meeting Proxy Statement filed March 21, 2025
- ·SEC website: https://www.sec.gov; Janus Henderson IR: https://ir.janushenderson.com
20-03-2026
Belpointe PREP, LLC reported total assets of $564.2M as of Dec 31, 2025, up 9% YoY from $517.6M, driven by real estate net growth to $531.9M (+10% YoY), while revenue surged 244% YoY to $9.2M. However, net loss attributable to the company widened 68% YoY to $40.0M from $23.9M, with loss per Class A unit deteriorating to $(10.72) from $(6.56), amid higher debt ($260.6M, +47% YoY), elevated interest expense (+74% YoY), and negative NOI across Commercial (-$1.1M) and Mixed-use (-$1.3M) segments.
- ·Cash flows used in operating activities worsened to $(25.2M) in 2025 from $(13.7M) in 2024.
- ·Cash flows from financing activities declined to $87.0M in 2025 from $157.0M in 2024, leading to a net cash decrease of $0.2M.
- ·Commercial Segment NOI: $(1.1M) in 2025 vs $(0.05M) in 2024; Mixed-use Segment NOI: $(1.3M) in 2025 vs $(1.4M) in 2024 (slight improvement but still negative).
20-03-2026
News Corporation filed an 8-K on March 20, 2026, disclosing information provided to the Australian Securities Exchange (ASX) regarding its ongoing $1B stock repurchase program for Class A and Class B common stock, as required under ASX rules for daily transaction reporting. Exhibits 99.1 and 99.2 contain the specific details provided to the ASX on the respective dates noted therein. No specific repurchase transactions or amounts are detailed in the filing body.
- ·Filing relates to Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- ·Securities: Class A Common Stock (NWSA), Class B Common Stock (NWS), both on Nasdaq Global Select Market.
20-03-2026
This 10-K filing dated March 20, 2026, includes servicing compliance assertions under Regulation AB 1122(d) for asset-backed securities pool assets by multiple servicers including Midland, Berkadia, PBLS1, Special Servicer, and Asserting Party. Most applicable servicing criteria across general servicing, cash collection, investor reporting, and pool asset administration are marked as performed directly or by responsible vendors/subservicers, with several criteria designated N/A or not performed where inapplicable to the parties' roles. No material non-compliance or exceptions are reported.
20-03-2026
The 10-K filing includes servicing compliance assessments under Regulation AB Rule 1122(d) for servicers Midland and K-Star related to asset-backed securities. Midland performs most criteria directly or via responsible vendors, with several marked N/A, while K-Star has numerous criteria not performed by it or its subservicers. No material noncompliance is noted across the tables, though certain investor reporting and pool asset administration criteria are inapplicable or handled by non-responsible parties.
- ·Filing date: March 20, 2026
- ·Multiple criteria marked N/A or inapplicable, including back-up servicer maintenance (1122(d)(1)(iii)) and certain investor remittance criteria (1122(d)(3)(ii)-(iv))
- ·K-Star has several criteria not performed by it or retained subservicers, such as investor reports (1122(d)(3)(i)) and pool asset safeguarding (1122(d)(4)(ii))
20-03-2026
The 10-K filing includes Appendix B detailing compliance with Regulation AB servicing criteria (1122(d)) for asset-backed securities by multiple servicers, including the Company, Torchlight Loan Services, PBLS, and CoreLogic. While the primary Company and Torchlight directly perform or oversee most criteria related to cash collection, pool asset administration, and general servicing, several key areas such as investor remittances/reporting (e.g., 1122(d)(3)(i)(B)-(D)), pool asset safeguarding (1122(d)(4)(ii)), and external enhancements (1122(d)(4)(xv)) are marked as not performed or inapplicable across servicers. Appendix A lists legacy MBS deals primarily from 2006-2007 involving trusts like AAMES, American Home Mortgage, and Accredited.
- ·Filing date: March 20, 2026
- ·Common timeframes referenced: deposits/postings within 2 business days; reconciliations within 30 calendar days; escrow analysis annually; resolutions within 90 calendar days
- ·Multiple criteria marked 'NOT performed' including back-up servicer maintenance (1122(d)(1)(iii)), certain investor reporting/filing (1122(d)(3)(i)(C/D)), and pool asset record agreements (1122(d)(4)(v))
20-03-2026
Unknown Company's 10-K annual report filed on March 20, 2026, includes multiple assessments of servicing criteria compliance under Regulation AB Item 1122 for asset-backed securities servicers such as Midland and CoreLogic. The tables confirm that most applicable criteria are performed directly by the servicers or by vendors for which they are responsible, with no noted deficiencies or exceptions. Several criteria are designated as not applicable (N/A) or inapplicable based on transaction agreements, indicating routine compliance without any highlighted issues.
20-03-2026
Embecta Corp. (Nasdaq: EMBC) announced a definitive agreement to acquire Owen Mumford Holdings Limited for up to £150 million (£100 million upfront cash plus up to £50 million in performance-based payments tied to Aidaptus® sales over three years post-closing). Owen Mumford generated £69.4 million in net revenue for its FY2025 (ended September 30), with approximately 80% from the UK and U.S., positioning the deal to expand Embecta's drug delivery portfolio and global reach. While expected to drive revenue growth and be accretive to adjusted net income after FY2028 with high-single-digit ROIC by year four, the acquisition will be dilutive to adjusted net income in FY2027.
- ·Expected closing in Embecta's fiscal Q3 2026, subject to regulatory approvals.
- ·Owen Mumford FY ends September 30.
- ·Financed by borrowings under Embecta's revolving credit facility.
- ·To be discussed on FY2026 Q2 earnings call on May 5, 2026.
- ·Owen Mumford founded in 1952, family-owned, headquartered in Oxfordshire, UK.
20-03-2026
Revenues and other income surged 61.7% YoY to $79.6M in 2025 from $49.2M in 2024, primarily driven by collaboration agreements rising to $72.1M (76.2% increase) and other revenues up 43.9% to $0.9M. However, net loss attributable to shareholders widened 83.9% to $67.6M from $36.8M, operating expenses increased with R&D up 3.3% to $93.5M and SG&A up 3.7% to $19.8M, cash and cash equivalents fell 19.8% to $208.7M, and shareholders' equity declined 42.1% to $75.9M.
- ·EPS basic and diluted FY2025: ($0.67), worsened from ($0.41) in FY2024.
- ·Total assets declined 15.4% to $324.7M as of Dec 31, 2025 from $383.5M.
- ·Adjusted Net Loss attributable to shareholders FY2025: $61.5M, vs $33.6M in FY2024.
20-03-2026
Pelican Acquisition Corporation held an extraordinary general meeting on March 19, 2026, where shareholders overwhelmingly approved all six proposals related to the business combination with Greenland Energy Company, including the Business Combination Proposal (6,509,645 for, 400,135 against) and others with similar strong support. However, holders redeemed 7,562,343 ordinary shares (out of 11,998,750 outstanding) for $77.7M at $10.28 per share, representing significant cash outflow from the trust. The transactions are expected to close around March 24, 2026, with Greenland Energy's stock trading as GLND on Nasdaq starting March 25, 2026.
- ·Record date for shareholder meeting: February 19, 2026.
- ·Proposal 6 (Incentive Plan Proposal) had slightly lower support: 6,505,085 for, 403,345 against, 126,448 abstain.
- ·Adjournment Proposal not presented due to sufficient votes for approval.
- ·Merger Agreement dated September 9, 2025.
20-03-2026
Pelican Acquisition Corporation held an extraordinary general meeting on March 19, 2026, where shareholders overwhelmingly approved all six proposals related to the business combination with Greenland Energy Company, including the Business Combination, Conversion, and Governing Documents Proposals. However, in connection with the meeting, holders redeemed 7,562,343 ordinary shares (63% of outstanding shares) for $77.7M at $10.28 per share, significantly reducing trust account funds. The merger is expected to close on or around March 24, 2026, with Greenland's stock trading under 'GLND' on Nasdaq starting March 25, 2026.
- ·Record date: February 19, 2026
- ·Merger Agreement dated: September 9, 2025
- ·Proposal 1 (Business Combination): For 6,509,645; Against 400,135; Abstain 125,098
- ·Proposal 2 (Conversion): For 6,507,603; Against 402,162; Abstain 125,113
- ·Proposal 3 (Governing Documents): For 6,509,645; Against 400,135; Abstain 125,098
- ·Proposal 4 (Governing Documents Advisory): For 6,508,445; Against 401,335; Abstain 125,098
- ·Proposal 5 (Stock Issuance): For 6,506,635; Against 403,145; Abstain 125,098
- ·Proposal 6 (Incentive Plan): For 6,505,085; Against 403,345; Abstain 126,448
20-03-2026
Appendix B of the 10-K filing details the Unknown Company's compliance assertions under Regulation AB servicing criteria for asset-backed securities, with most general servicing considerations, cash collection, and certain pool asset administration criteria marked as performed directly (X) or by responsible vendors. However, numerous investor remittances and reporting criteria (e.g., 1122(d)(3)(i)(B)-(D), (ii)-(iv)) and some pool asset administration items are marked as not performed by the company or its subservicers. CoreLogic's separate table shows compliance with select criteria like fidelity bonds and reconciliations but marks many others as not performed.
- ·Filing Date: March 20, 2026
- ·Standard timeframes referenced: 2 business days for deposits/postings, 30 calendar days for reconciliations/escrow returns, 90 calendar days for reconciling items
20-03-2026
Pelican Acquisition Corp, a SPAC, reported net income of $1.25M for the year ended January 31, 2026, compared to a $42.6k loss in the prior inception-to-January 31, 2025 period, primarily driven by $2.35M in interest income from its newly funded $88.6M Trust Account holding 8,625,000 redeemable shares at $10.27 per share post-IPO. However, general and administrative expenses surged to $1.1M from $43k, leading to a $1.1M operational loss, while shareholders' deficit widened to $(405k) from $(13k). Total assets grew to $88.8M from $208k, reflecting IPO proceeds, but cash remained minimal at $77.
- ·Promissory note – related party: $0 at Jan 31, 2026 (down from $200k at Jan 31, 2025)
- ·Due to target company (Greenland): $100k as of Jan 31, 2026
- ·IPO-related: Private Placement Units issuance raised $2.99M; Public Rights net $1.34M
- ·Remeasurement of carrying value to redemption value: $(4.5M) and $(888k); Accretion $(792k)
20-03-2026
Primoris Services Corporation (NYSE: PRIM) has issued its 2026 Proxy Statement for the virtual Annual Meeting of Stockholders on April 30, 2026, at 9:00 a.m. CT, where shareholders will vote on electing eight directors, advisory approval of named executive officer compensation, and ratification of Baker Tilly US, LLP as independent auditors for the fiscal year ending December 31, 2026. The company describes 2025 as an exceptional year, achieving record milestones, accelerating strategic growth, generating strong cash flow, and strengthening its balance sheet. Chairman David L. King thanks retiring Board member John Schauerman for his long service.
- ·Record date for shareholders entitled to vote: March 9, 2026
- ·Virtual meeting registration deadline: April 24, 2026, 11:59 p.m. Central Time at www.proxydocs.com/PRIM
- ·Principal executive offices: 2300 N. Field Street, Suite 1900, Dallas, Texas 75201
20-03-2026
Yellowstone MidCo Holdings II, LLC reported revenue growth of 52% YoY to $386M for 2025 from $254M in 2024, with gross profit tripling to $75M (20% margin from 13%) and Adjusted EBITDA improving to -$8M from -$43M. However, the company posted a net loss of $85M (narrowed 15% YoY), operating expenses increased 17% driven by higher SG&A (+11%) and transaction costs, R&D declined 10%, and net cash used in operations was $121M versus provided by $32M prior year.
- ·Net EAC adjustments before taxes: -$11.1M in 2025 vs -$22.9M in 2024.
- ·Minimum revenue guarantees extend to Sep 2028 at $758M.
- ·Cash increased $58M to $163M end-2025, driven by $204M financing inflows.
20-03-2026
Orla Mining Ltd., a Canadian mining company, filed its Form 40-F Annual Report for the fiscal year ended December 31, 2025, on March 20, 2026, pursuant to SEC requirements for foreign private issuers. The filing discloses details on operating segments including Musselwhite Mine and Camino Rojo, property, plant and equipment across mining properties, derivatives such as gold forward contracts and silver stream arrangements, equity instruments like share options, restricted share units, performance share units, and warrants, as well as financial risks including commodity price, currency, and interest rate risks. Contingent considerations for business combinations, such as with Musselwhite Mine Ltd., are linked to gold spot prices exceeding $2,900/oz or $3,000/oz, with no specific performance metrics showing growth or declines provided in the extracted tags.
- ·Filing covers FY ended December 31, 2025, with comparative data tags for 2024 and 2023 periods.
- ·Debt instruments include Convertible Notes maturing January 1, 2026, Revolving Facility, and Term Facility.
- ·Equity plans: Performance Share Units granted March 2023, Restricted Share Units vesting over 1-3 years post-award, Deferred Share Unit Plan.
- ·Risk disclosures cover IFRS inputs like share price, maturity, exercise price, interest rates, and historical volatility as of December 31, 2025, and February 28, 2025.
20-03-2026
Unknown Company's 10-K annual report includes Appendix B, detailing compliance assessments for Regulation AB servicing criteria related to asset-backed securities servicing. The company and related servicers (e.g., CoreLogic, KeyBank) report performing most criteria directly or via responsible vendors in areas like general servicing, cash collection, and pool asset administration; however, numerous investor remittances and reporting criteria (e.g., 1122(d)(3)(i)(B)-(D), (ii)-(iv)) are marked as not performed by the company/subservicers or inapplicable, particularly for Platform B.
- ·Servicing criteria timeframes include deposits/postings within 2 business days, reconciliations within 30 calendar days, and resolution of reconciling items within 90 calendar days.
- ·Multiple criteria (e.g., 1122(d)(1)(iii), 1122(d)(3)(ii)-(iv), 1122(d)(4)(ii),(xv)) marked as 'NOT performed by the Company or subservicers' or 'Inapplicable'.
- ·Fidelity bond and errors/omissions policy confirmed in effect per transaction agreements.
20-03-2026
For the year ended December 31, 2025, Unknown Company reported total investment income of $42.1M, up 87% YoY from $22.5M in 2024, with net investment income increasing 91% to $20.3M and net increase in member's capital rising 93% to $17.6M. Total assets expanded 72% to $572M, driven by investments growing to $546M at fair value. However, weighted average yield on debt investments declined to 9.1% from 10.0%, net asset value per unit fell 1.2% to $1,788, and unrealized depreciation reached $3.1M versus $0.9M appreciation in 2024.
- ·Debt increased 92% to $332.6M from $173.6M.
- ·Common units outstanding grew 52% to 129,757 from 85,248.
- ·Percentage of first lien secured debt rose slightly to 99.7% from 98.8%.
- ·Weighted average EBITDA increased to $228 from $209.
20-03-2026
For the year ended December 31, 2025, Unknown Company reported total investment income of $110.5M, up 110% YoY from $52.6M in 2024, with net investment income increasing 78% to $52.1M and net assets expanding to $677M from $356M. However, weighted average yield on debt investments declined to 9.1% from 10.0% (at amortized cost), net unrealized depreciation reached $6.7M versus $2.1M appreciation in 2024, and NAV per share slipped to $14.43 from $14.60. The portfolio grew to $1.57B in fair value investments, nearly all first-lien (99.7%) and floating-rate (99.9%), while debt leverage rose to $919M.
- ·Interest income $105.5M in 2025 (up from $50.5M in 2024); payment-in-kind $2.1M (up from $0.8M).
- ·Net expenses $58.4M in 2025 (up from $23.4M); interest expense $44.8M (up from $22.4M).
- ·Net realized gain $0.9M in 2025 vs loss $5.5M in 2024.
- ·Weighted average EBITDA $226 (2025) vs $208 (2024).
- ·Interest rate sensitivity: +200 bps net income impact +$13.2M; -200 bps -$13.2M.
- ·Inception date: December 4, 2023.
20-03-2026
StimCell Energetics Inc. (OTCQB: STME) engaged Stonegate Capital Partners, Inc. for research coverage and institutional investor outreach under an Advisory Services Agreement effective March 12, 2026, with services including quarterly research updates and coordination of investor meetings for a 12-month term. Compensation consists of 250,000 shares of common stock issued to Stonegate. CEO David Jeffs highlighted the partnership's potential to elevate visibility and build institutional ownership for the company's eBalance® technology.
- ·Shares subject to a six-month hold period from issuance date.
- ·Shares issued pursuant to exemptions from prospectus requirements of Canadian securities laws and registration requirements of U.S. Securities Act of 1933.
- ·Company focuses on products enhancing cellular function for wellness, anti-aging, insulin sensitivity, high blood pressure, neuropathy, and kidney function.
20-03-2026
Unknown Company's 10-K for the year ended December 31, 2025, shows total assets surging to $329,803 from $1,015 at year-end 2024, driven by net certificate issuances of approximately $327k (related parties $231k issued net of surrenders, third parties $100k net) boosting cash and equivalents to $329,526. However, net loss widened significantly to $3,070 from $574 YoY due to elevated expenses ($3,077 vs $574) and new $1,270 provision for certificate reserves, while stockholder’s equity edged up only slightly to $584 from $521. Interest income commenced at $1,277, but overall performance reflects early-stage growth amid deepening losses.
- ·Company inception date: April 13, 2023
- ·Filing date: March 20, 2026
- ·Capital contributions from Parent: $3,133 in 2025 (total additional paid-in-capital $4,259)
- ·No income tax provision recorded in any period
- ·Net cash provided by operating activities: $1,285 in 2025 vs $0 in 2024
- ·Certificate surrenders: related parties $3,439, third parties $14,514 in 2025
- ·Accumulated deficit: $(3,675) as of Dec 31 2025
20-03-2026
Unknown Company's 10-K filing includes Appendix B, a Regulation AB servicing criteria compliance assessment for asset-backed securities servicers. Multiple entities, including the Company, KeyBank, CoreLogic, and Midland, report that most applicable criteria (e.g., cash collection, pool asset administration) are performed directly or via responsible vendors, while several investor reporting and remittance criteria are marked as inapplicable or not performed. No material deficiencies or exceptions are disclosed, indicating standard compliance where required.
- ·Several criteria under 1122(d)(3) (Investor Remittances and Reporting) marked as inapplicable (N/A) or not performed (X) by the Company and KeyBank.
- ·Back-up servicer maintenance (1122(d)(1)(iii)) not performed by the Company.
- ·Pool asset documents safeguarding (1122(d)(4)(ii)) not performed by the Company.
20-03-2026
Appendix B of Unknown Company's 10-K filing details compliance assessments for Regulation AB Rule 1122(d) servicing criteria related to asset-backed securities and mortgage loans. Multiple servicers, including the Company, CWCAM, PBLS1, CoreLogic, and KeyBank, indicate that most general servicing, cash collection, and certain pool asset administration criteria are performed directly or via responsible vendors. However, numerous criteria under Investor Remittances and Reporting (e.g., 1122(d)(3)(i)(B)-(D), (ii)-(iv)) and Pool Asset Administration (e.g., 1122(d)(4)(v), (ix)-(xv)) are marked as not applicable, not performed, or handled by non-responsible parties.
- ·Several criteria require actions within 2 business days (e.g., deposits, posting disbursements), 30 calendar days (e.g., reconciliations, escrow returns), or 90 calendar days (reconciling items).
- ·Back-up servicer maintenance (1122(d)(1)(iii)) is not performed by the Company or certain subservicers.
20-03-2026
The 10-K annual report filed on March 20, 2026, includes detailed assessments of compliance with Regulation AB Servicing Criteria (Item 1122(d)) for asset-backed securities servicers such as Midland and Berkadia. Most criteria across general servicing, cash collection, investor reporting, and pool asset administration are marked as performed directly by the servicer or by vendors/subservicers for which they are responsible, while others are designated N/A or not performed due to inapplicability. No material non-compliance or exceptions are noted in the tables.
20-03-2026
For the year ended December 31, 2025, the company expanded its portfolio to 86 companies (up 26% from 68) and grew total assets to $1.46B (78% increase) and net assets to $708M (83% increase), with total investment income nearly doubling to $98.3M. However, weighted average yields on debt investments compressed to 8.8-8.9% from 9.8%, net investment activity declined 27% to $546k, and unrealized appreciation shifted to a $3.2M depreciation from a $8.1M gain, contributing to a slight 0.4% decline in NAV per share to $1,031.53.
- ·Credit facilities increased to $726M from $419M.
- ·Net operating expenses rose to $35.9M from $20.0M, with full management fees waived ($6.6M).
- ·Interest rate sensitivity: Down 250 bps would reduce net interest income by 18.4%; up 250 bps would increase it by 18.4%.
20-03-2026
This 10-K filing includes servicing compliance assertions under Regulation AB Item 1122 for asset-backed securities, with Midland and KeyBank confirming adherence to most applicable servicing criteria through direct performance or responsible vendor oversight. Several criteria, particularly in investor remittances and reporting, are marked as N/A or not applicable, while others like back-up servicer maintenance are also N/A. No material deficiencies or exceptions are noted in the disclosures.
- ·Multiple footnotes reference specific transaction agreements (e.g., N/A1 for back-up servicer, X2 for advances and reporting)
- ·Servicing criteria reconciliations prepared monthly within 30 days and resolved within 90 days where applicable
- ·Funds held in escrow analyzed annually and returned within 30 days of repayment
20-03-2026
Cingulate Inc. filed an S-3 registration statement on March 20, 2026, to register up to 3,500,000 shares of common stock (part of a total 6M including prior registration) for resale by Lincoln Park under a July 21, 2025 Purchase Agreement committing up to $25M in common stock purchases over 36 months. The company issued 120,424 commitment shares to Lincoln Park without cash consideration. While this facility offers flexible capital access subject to market conditions and a $0.50 minimum price, it poses substantial dilution risks to existing shareholders, potential stock price declines, and limitations on full utilization due to ownership caps.
- ·Purchase Agreement entered July 21, 2025; 36-month term commencing after conditions met.
- ·Prior S-1 registration filed July 25, 2025 (effective July 29, 2025) for 2,500,000 shares.
- ·Regular Purchases allowed only if last closing sale price >= $0.50.
- ·Agreement terminable by company with one business day's notice without penalty.
20-03-2026
Firefly Aerospace reported revenue of $159.9M for 2025, up 163% YoY from $60.8M, driven by strong growth in Spacecraft Solutions (+244% to $131.2M) and Launch revenue (+26% to $28.6M); gross profit swung to $30.7M from a $11.4M loss. However, net loss widened 29% YoY to $298.3M, operating loss increased 24% to $260.7M amid 47% higher operating expenses, and cash used in operations rose 30% to $204.9M, though bolstered by $1.3B in financing inflows.
- ·Adjusted EBITDA was -$198.6M in 2025, worsening from -$190.6M in 2024.
- ·Free cash flow was -$237.8M in 2025, down from -$190.3M in 2024.
- ·Total assets grew to $1.8B from $407.3M; cash equivalents rose to $793M from $123.4M.
- ·Intangible assets $165.7M and goodwill $450.1M as of Dec 31 2025, primarily from acquisitions.
- ·Net loss per common share improved to -$4.83 from -$20.74, with weighted-average shares 69,204 vs 12,819.
20-03-2026
Innovator ETFs Trust filed a DEFA14A on March 20, 2026, as definitive additional proxy materials to solicit shareholder votes for an unspecified proposal affecting the fund. The notice urges unvoted shareholders to act immediately via online QR code scan, phone (1-866-217-8062), or link to materials, with Sodali & Co. handling solicitation during specified hours. No financial metrics or performance data are disclosed.
- ·Solicitation hours: Monday–Friday 10:00 a.m. to 11:00 p.m. ET; Saturday 12:00 p.m. to 5:00 p.m. ET
- ·Phone for voting: 1-866-217-8062
- ·Reference number example: INETF IA3
- ·Proxy materials link: https://proxyvotinginfo.com/p/innovatoretfs2026
20-03-2026
This 10-K Appendix B details compliance with Regulation AB servicing criteria (1122(d)) for asset-backed securities, primarily mortgage-backed trusts, where the Company, Midland, and CoreLogic assert that most applicable criteria are performed directly or by responsible vendors. Several criteria are marked as not performed or inapplicable (e.g., back-up servicer maintenance, certain investor reporting), reflecting standard limitations for their servicing roles rather than deficiencies. Appendix A lists specific MBS deals such as AAMES MORTGAGE INVESTMENT TRUST 2006-1 and American Home Mortgage Investment Trust 2006-1 through 2006-3.
- ·Filing Date: March 20, 2026
- ·Multiple criteria marked N/A or not performed (e.g., 1122(d)(1)(iii) back-up servicer, 1122(d)(3)(ii)-(iv) investor remittances)
20-03-2026
Unknown Company's 10-K filing dated March 20, 2026, includes Appendix B assessing compliance with Regulation AB servicing criteria (1122(d)) for asset-backed securities transactions. The company or asserting party directly performs or oversees via responsible vendors most criteria in general servicing, cash collection/administration, and pool asset administration, such as monitoring defaults, payment deposits within two business days, and loss mitigation. However, numerous investor remittances/reporting criteria (e.g., 1122(d)(3)(i)(B)-(D), (ii)-(iv)) and others like back-up servicer maintenance and pool asset safeguarding are marked as not performed or inapplicable.
- ·CoreLogic table marks most criteria as not performed by CoreLogic or its subservicers.
- ·Multiple tables show variations: some criteria applicable only to specific platforms (e.g., 1122(d)(3)(i)(C/D) applicable for Platform A, not B).
20-03-2026
Prestige Consumer Healthcare Inc. announced an agreement to acquire the Breathe Right portfolio, including the #1 nasal strip brand, from Foundation Consumer Healthcare for $1.045B in cash (~$900M net of anticipated tax benefits), adding ~$200M LTM revenue (ended Dec 31, 2025) and ~$95M EBITDA at 11.0x multiple (9.5x net). The deal is immediately accretive to revenue, margins, EPS, and FCF, boosting pro-forma revenue to ~$1.3B from standalone ~$1.1B, financed by cash and new term loan with pro-forma net leverage ~4.0x at close (expected H1 FY27) and path to <3.0x by FY28. Historically, FY20-FY25 CAGRs show revenue +3.4%, organic revenue +2.4%, and adjusted EPS +8.8%, reflecting steady but modest organic growth.
- ·Target portfolio: 71% US & Canada revenue, 29% international (mostly Europe).
- ·Breathe Right provides ~30% immediate nasal airflow increase; loyal users average 150+ strips/year.
- ·Acquisition expected to close H1 FY27 (by Sep 30, 2026), subject to regulatory approvals.
- ·Historical net leverage: 4.1x Q2 FY22, down to 2.4x FY25 and FY26E.
- ·Prestige FY25 adjusted net income $226.3M (GAAP $214.6M); FY20 adjusted $151.3M (GAAP $142.3M).
20-03-2026
Dollar General's FY2025 net sales rose 5.2% YoY to $42.7B from $40.6B in FY2024, driven by 6.7% growth in home products and 6.2% in seasonal, while consumables grew 5.0% and apparel a modest 3.3%; average sales per square foot increased to $270 from $263. Operating profit surged 28.6% to $2.2B with gross margin expanding 107 bps to 30.66%, and net income climbed 34.4% to $1.5B. However, profitability metrics remained below FY2023 levels, with operating profit down 29.9% from $2.4B and net margin at 3.54% versus 4.29%.
- ·Average sales per square foot: $270 in FY2025 (up from $263 in FY2024)
- ·FY2025 SG&A expenses: $10.9B (5.8% YoY increase)
- ·FY2025 diluted EPS: $6.85 (34.1% YoY increase from $5.11)
- ·Self-insurance liabilities: $377.6M total
Get daily alerts with 12 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)